The primary aims of this cross-sectional study from India were to evaluate the proportion of MUC5B promoter polymorphism in different subtypes of ILD and to establish diagnostic cut-offs for serum KL-6 and MMP7 to distinguish ILD patients from healthy controls. This evidence concerns the gene MUC1 and interstitial lung disease.